SEMA NEWS
Live Now
New drug suzetrigine, known by its brand name Journavx, has been approved to treat moderate to severe pain.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.